Komori
Changes in Officers3202Daitobo Co.,Ltd.Materials and Chemicals

Notice Concerning the Organizational Restructuring of the Healthcare Business and Personnel Changes

The healthcare business will be divided into product and materials businesses, with a new Healthcare Products Business Division established for the product business, while the materials business will be transferred to the Textile Business Division. In connection with this change, the departments and positions assigned to division-manager-level personnel, including directors, will be changed.

Worth reading
30Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 15 October 2026
Scheduled Appointment Date1 November 2026
Reason for change

To optimize the allocation of management resources in line with the characteristics of each business and strengthen earning power, the company will reorganize its healthcare business and make personnel changes at the division-manager level in connection with the reorganization, effective 1 November 2026.

Details of organizational changes

Establish the Healthcare Products Business Division, including the HC Products Sales Department and Sales Support Group. Abolish the Textile Business Division's Textile Sales Department and establish the Products Sales Department and Textile Sales Department. Establish the Uniforms Group and Healthcare Group within the Textile Sales Department. Transfer the healthcare-related materials business to the Healthcare Group within the Textile Sales Department.

Who is moving to which position
ItemDetails
Resolution date15 October 2026
Scheduled Appointment Date1 November 2026
Reason for changeTo optimize the allocation of management resources in line with the characteristics of each business and strengthen earning power, the company will reorganize its healthcare business and make personnel changes at the division-manager level in connection with the reorganization, effective 1 November 2026.
Details of organizational changesEstablish the Healthcare Products Business Division, including the HC Products Sales Department and Sales Support Group. Abolish the Textile Business Division's Textile Sales Department and establish the Products Sales Department and Textile Sales Department. Establish the Uniforms Group and Healthcare Group within the Textile Sales Department. Transfer the healthcare-related materials business to the Healthcare Group within the Textile Sales Department.
Items this document does not state (17)
Date of departureName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To make efficient use of management resources based on the characteristics of the product and materials businesses and to clarify profitability by business, the company aims to strengthen coordination from product planning through development, manufacturing and sales, reduce manufacturing costs, optimize inventories, improve sales efficiency, create new sales opportunities and strengthen earning power.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Organizational Restructuring of the Healthcare Business and Personnel Changes | Daitobo Co.,Ltd. (3202) timely disclosure | Komori